Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 17/20 | 0.60 |
| ▸ | NPY1R | P25929 | 11/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.60 |
| ▸ | NPY2R | P49146 | 7/20 | 0.60 |
| ▸ | TFPI | P10646 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29476505 | 1.00 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL29476428 | 1.00 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787055 | 1.00 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787041 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787062 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787048 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787044 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787061 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787054 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30787057 | 0.96 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711004-A2 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS | Rhythm Pharmaceuticals, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |